Exact Sciences Corporation (EXAS) Earnings History
Net Loss27 years of earnings data (1999–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Exact Sciences Corporation (EXAS) Earnings Overview
As of June 22, 2026, Exact Sciences Corporation (EXAS) reported trailing twelve-month net income of -$208M, reflecting +80.3% year-over-year growth. The company earned $-1.10 per diluted share over the past four quarters, with a net profit margin of -6.4%.
Looking at the long-term picture, EXAS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 1999.
Exact Sciences Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including GH (-$433M net income, -42.4% margin), NTRA (-$226M net income, -9.0% margin), ILMN ($853M net income, 19.6% margin), EXAS has outperformed on profitability metrics. Compare EXAS vs GH →
EXAS Earnings vs Peers
Earnings metrics vs comparable public companies
EXAS Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$208M | +79.8% | -$206M | $-1.10 | -6.4% | -6.4% |
| 2024 | -$1.03B | -404.0% | -$1.05B | $-5.59 | -37.3% | -38.0% |
| 2023 | -$204M | +67.3% | -$215M | $-1.13 | -8.2% | -8.6% |
| 2022 | -$624M | -4.7% | -$594M | $-3.54 | -29.9% | -28.5% |
| 2021 | -$596M | +27.7% | -$856M | $-3.48 | -33.7% | -48.4% |
| 2020 | -$824M | -286.5% | -$768M | $-5.45 | -55.2% | -51.5% |
| 2019 | -$213M | -21.7% | -$234M | $-1.62 | -24.3% | -26.7% |
| 2018 | -$175M | -53.1% | -$159M | $-1.43 | -38.5% | -35.1% |
| 2017 | -$114M | +31.6% | -$118M | $-0.99 | -43.0% | -44.5% |
| 2016 | -$167M | -6.0% | -$169M | $-1.63 | -168.3% | -170.1% |
| 2015 | -$158M | -57.7% | -$159M | $-1.71 | -400.1% | -403.3% |
| 2014 | -$100M | -115.1% | -$101M | $-1.25 | -5564.4% | -5591.7% |
| 2013 | -$47M | +11.3% | -$47M | $-0.69 | -1122.4% | -1128.4% |
| 2012 | -$52M | -82.8% | -$53M | $-0.88 | -1265.0% | -1270.3% |
| 2011 | -$29M | -148.1% | -$29M | $-0.55 | -688.8% | -692.4% |
| 2010 | -$12M | -27.1% | -$12M | $-0.28 | -216.2% | -221.3% |
| 2009 | -$9M | +6.7% | -$9M | $-0.28 | -191.0% | -193.5% |
| 2008 | -$10M | +18.5% | -$10M | $-0.36 | - | - |
| 2007 | -$12M | +7.4% | -$13M | $-0.44 | -407.5% | -437.7% |
| 2006 | -$13M | +11.1% | -$14M | $-0.49 | -271.9% | -298.3% |
| 2005 | -$15M | +21.6% | -$16M | $-0.55 | -341.6% | -367.9% |
| 2004 | -$19M | +34.6% | -$19M | $-0.73 | -375.3% | -389.0% |
| 2003 | -$28M | +5.2% | -$29M | $-1.50 | -976.9% | -994.1% |
| 2002 | -$30M | -27.2% | -$31M | $-1.62 | -3331.4% | -3438.7% |
| 2001 | -$23M | -97.6% | -$26M | $-1.42 | -46167.5% | -51406.4% |
| 2000 | -$12M | -139.4% | -$10M | $-8.13 | - | - |
| 1999 | -$5M | - | -$5M | $-3.40 | - | - |
Download Data
Export EXAS earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into EXAS consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
EXAS — Frequently Asked Questions
Quick answers to the most common questions about buying EXAS stock.
What is EXAS earnings per share (EPS)?
EXAS trailing twelve-month (TTM) diluted EPS is $-1.10, reflecting +80.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1999 to 2025 is available in the table on this page.
What is Exact Sciences Corporation's net income?
Exact Sciences Corporation (EXAS) trailing twelve-month net income is $-208M as of 2025. Earnings grew +80.3% year-over-year.
Is EXAS profitable?
EXAS is not currently profitable on a TTM basis, reporting a net loss of $-208M. Net margin is -6.4%. Investors should monitor for a return to profitability.
What is EXAS's earnings growth rate?
EXAS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1999 to 2025.
What are EXAS's profit margins?
Exact Sciences Corporation net profit margin is -6.4%, operating margin is -6.4%, and gross margin is +69.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -8.7%.
Is EXAS growing earnings?
Yes, EXAS earnings are accelerating — EPS growth of +80.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-208M. Earnings momentum is strengthening.
What was EXAS's best earnings year?
Exact Sciences Corporation's highest annual net income on record is $-5M, achieved in fiscal year 1999. Earnings history on this page spans 1999 to 2025 and includes all annual and quarterly figures.
What were EXAS's earnings last quarter?
EXAS's most recent reported quarter was Q4 2025. Net income was $-86M with diluted EPS of $-0.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.